IT1269578B - Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. - Google Patents

Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.

Info

Publication number
IT1269578B
IT1269578B ITMI940790A ITMI940790A IT1269578B IT 1269578 B IT1269578 B IT 1269578B IT MI940790 A ITMI940790 A IT MI940790A IT MI940790 A ITMI940790 A IT MI940790A IT 1269578 B IT1269578 B IT 1269578B
Authority
IT
Italy
Prior art keywords
base
cyclodestrine
inclusion complexes
acid type
high solubility
Prior art date
Application number
ITMI940790A
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Canale Maurizio Del
Enrico Redenti
Daniela Acerbi
Massimo Pasini
Josef Sjeitli
Maria Vikmon
Eva Fenyvesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI940790A0 publication Critical patent/ITMI940790A0/it
Priority to ITMI940790A priority Critical patent/IT1269578B/it
Priority to AT95916656T priority patent/ATE194777T1/de
Priority to PCT/EP1995/001407 priority patent/WO1995028965A1/en
Priority to ES95916656T priority patent/ES2148512T3/es
Priority to CA002188388A priority patent/CA2188388A1/en
Priority to AU23076/95A priority patent/AU2307695A/en
Priority to DE69518070T priority patent/DE69518070T2/de
Priority to EP95916656A priority patent/EP0756493B1/en
Priority to US08/722,220 priority patent/US5773029A/en
Priority to PT95916656T priority patent/PT756493E/pt
Priority to IL11345095A priority patent/IL113450A/xx
Priority to ZA953206A priority patent/ZA953206B/xx
Publication of ITMI940790A1 publication Critical patent/ITMI940790A1/it
Application granted granted Critical
Publication of IT1269578B publication Critical patent/IT1269578B/it
Priority to HK98114995A priority patent/HK1013627A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
ITMI940790A 1994-04-22 1994-04-22 Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. IT1269578B (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ITMI940790A IT1269578B (it) 1994-04-22 1994-04-22 Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.
DE69518070T DE69518070T2 (de) 1994-04-22 1995-04-13 Mehrfachkomponenten-inklusionskomplexe enthaltend einen sauren arzneistoff, ein zyklodextrin und eine base
US08/722,220 US5773029A (en) 1994-04-22 1995-04-13 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
ES95916656T ES2148512T3 (es) 1994-04-22 1995-04-13 Complejos de inclusion multicomponentes de alta solubilidad que constan de una sustancia farmaceutica acidica, una ciclodextrina y una base.
CA002188388A CA2188388A1 (en) 1994-04-22 1995-04-13 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
AU23076/95A AU2307695A (en) 1994-04-22 1995-04-13 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
AT95916656T ATE194777T1 (de) 1994-04-22 1995-04-13 Mehrfachkomponenten-inklusionskomplexe enthaltend einen sauren arzneistoff, ein zyklodextrin und eine base
EP95916656A EP0756493B1 (en) 1994-04-22 1995-04-13 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
PCT/EP1995/001407 WO1995028965A1 (en) 1994-04-22 1995-04-13 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
PT95916656T PT756493E (pt) 1994-04-22 1995-04-13 Complexos de inclusao com componentes multiplos de elevada solubilidade que contem um medicamento acido uma ciclodextrina e uma base
IL11345095A IL113450A (en) 1994-04-22 1995-04-20 Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby
ZA953206A ZA953206B (en) 1994-04-22 1995-04-20 High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base
HK98114995A HK1013627A1 (en) 1994-04-22 1998-12-23 High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940790A IT1269578B (it) 1994-04-22 1994-04-22 Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.

Publications (3)

Publication Number Publication Date
ITMI940790A0 ITMI940790A0 (it) 1994-04-22
ITMI940790A1 ITMI940790A1 (it) 1995-10-22
IT1269578B true IT1269578B (it) 1997-04-08

Family

ID=11368715

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI940790A IT1269578B (it) 1994-04-22 1994-04-22 Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.

Country Status (13)

Country Link
US (1) US5773029A (it)
EP (1) EP0756493B1 (it)
AT (1) ATE194777T1 (it)
AU (1) AU2307695A (it)
CA (1) CA2188388A1 (it)
DE (1) DE69518070T2 (it)
ES (1) ES2148512T3 (it)
HK (1) HK1013627A1 (it)
IL (1) IL113450A (it)
IT (1) IT1269578B (it)
PT (1) PT756493E (it)
WO (1) WO1995028965A1 (it)
ZA (1) ZA953206B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997018245A1 (en) * 1995-11-14 1997-05-22 Farmarc Nederland B.V. Complex of naproxen and beta-cyclodextrin
UA57734C2 (uk) 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
PT811386E (pt) * 1996-05-07 2004-12-31 Pfizer Metodo de seleccao de um sal para a preparacao de um complexo de inclusao
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6939863B2 (en) 2002-01-04 2005-09-06 Wei-Jan Chen Prevention of atherosclerosis and restenosis
ATE419840T1 (de) * 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
DE60219609T2 (de) * 2002-06-17 2008-01-03 Chiesi Farmaceutici S.P.A. Prozess für die Vorbereitung von Piroxicam: Beta-Cyclodextrin Einschlusskomplexe
US7115587B2 (en) * 2002-08-20 2006-10-03 Bristol-Myers Squibb Company Aripiprazole complex formulation and method
DE10260872B4 (de) 2002-12-23 2013-09-26 Beiersdorf Ag Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
DE10260873A1 (de) * 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
US20070020578A1 (en) * 2005-07-19 2007-01-25 Scott Robert R Dental curing light having a short wavelength LED and a fluorescing lens for converting wavelength light to curing wavelengths and related method
US20080171687A1 (en) * 2004-09-16 2008-07-17 Abraxis Bioscience, Inc. Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
EP1954256A2 (en) * 2005-11-09 2008-08-13 Torrent Pharmaceuticals Ltd Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
WO2010138920A1 (en) 2009-05-29 2010-12-02 Cydex Pharmaceuticals, Inc. Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
CN108210501B (zh) 2016-12-14 2019-03-08 中国人民解放军军事医学科学院毒物药物研究所 一种磺酰脲类药物的注射用药物组合物及其制备方法
KR20230165778A (ko) * 2021-03-04 2023-12-05 바이오젠 체사피크 엘엘씨 저-흡수 글리부라이드 제형 및 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
FR2624731B1 (fr) * 1987-12-22 1992-10-23 Glaxo Group Ltd Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina

Also Published As

Publication number Publication date
IL113450A0 (en) 1995-07-31
CA2188388A1 (en) 1995-11-02
ATE194777T1 (de) 2000-08-15
WO1995028965A1 (en) 1995-11-02
US5773029A (en) 1998-06-30
PT756493E (pt) 2000-10-31
ZA953206B (en) 1996-01-03
IL113450A (en) 1999-05-09
DE69518070D1 (de) 2000-08-24
ITMI940790A0 (it) 1994-04-22
DE69518070T2 (de) 2001-01-11
EP0756493B1 (en) 2000-07-19
AU2307695A (en) 1995-11-16
ES2148512T3 (es) 2000-10-16
ITMI940790A1 (it) 1995-10-22
EP0756493A1 (en) 1997-02-05
HK1013627A1 (en) 1999-09-03

Similar Documents

Publication Publication Date Title
IT1269578B (it) Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.
ITMI930141A1 (it) Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
SE9504661D0 (sv) New compounds
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
RU2002109814A (ru) Новые производные аминодикарбоновых кислот, обладающие фармацевтическими свойствами
ATE167476T1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
FI931250A (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
ES2194003T3 (es) Huperzina a racemica.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
FI963394A (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
SE9504662D0 (sv) New compounds
ITTO910787A1 (it) Amplificatore di potenza, in particolare di tipo audio.
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
FI904932A0 (fi) Optiskt aktiva tiazetokinolin-3 -karboxylsyraderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
DE69627184D1 (de) 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970324